| Literature DB >> 32724647 |
Yu Zhou1, Yu Wang1, Qiong Pan1, Xi-Xi Wang1, Pei-Jun Li1,2, Ke-Zhou Cai1,2, Cong-Gui Chen1,2,3.
Abstract
Flavor loss from sodium reduction is a large challenge faced in the meat industry. The effects of salt mixture (KCl: CaCl2 = 1:1, w/w) content (0%-1.0%) on flavor of reduced-sodium (1.5% NaCl) restructured bacon with ultrasound treatment (UT, 600 w for 30 min) were investigated. The results showed that 0.5% salt mixture (0.25% KCl and 0.25% CaCl2) could significantly (p < .05) enhance the lipid oxidation, the protein oxidation, and the formation of free amino acids of reduced-sodium UT-restructured bacon and could also markedly (p < .05) improve its flavor and the overall quality of sensory evaluation via promoting the release of five kinds of volatile phenolic compounds (o-cresol, m-cresol, 2-methoxy-phenol, 2-methoxy-4-methylphenol, and 2-methoxy-5-methylphenol) and the formation of five kinds of volatile aldehyde compounds (hexanal, nonanal, decanal, furfural, and 5-methyl furfural). It is interesting to understand the mechanism for the effect of salt mixture on flavor and to efficiently develop a technique for improving the flavor of reduced-sodium products in the meat industry.Entities:
Keywords: lipid and protein oxidation; reduced‐sodium restructured bacon; salt mixture; ultrasound; volatile flavor compound
Year: 2020 PMID: 32724647 PMCID: PMC7382110 DOI: 10.1002/fsn3.1679
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Content of NaCl and salt mixture in reduced‐sodium restructured bacon under ultrasound treatments (U0, U1, U2, and U3)
| Treatments of four | Amount of salts added in g/100 g meat | ||
|---|---|---|---|
| NaCl | KCl | CaCl2 | |
| U0 (1.5%NaCl + UT 600 w) (Control) | 1.5 | 0 | 0 |
| U1 (1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w) | 1.5 | 0.125 | 0.125 |
| U2 (1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w) | 1.5 | 0.25 | 0.25 |
| U3 (1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w) | 1.5 | 0.5 | 0.5 |
The content of other additives in U0‐U3 were the same and were 0.5% sugar, 0.01% sodium nitrite, 2% soy protein isolate, 0.4% sodium tripolyphosphate, and 0.5% liquid smoke, 11.1% water, respectively.
Abbreviation: UT, ultrasound treatment.
Deviation of weight of all salts was not in excess of ± 0.5%.
FIGURE 1Lipid oxidation (a) and protein oxidation (b) of the reduced‐sodium restructured bacon under ultrasound treatment as affected by the content of salt mixture. a–d in the column indicates that the different letters are significantly different (p < .05, n = 3). *U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w
Effect of salt mixture on free fatty acid composition of the reduced‐sodium restructured bacon under ultrasound treatments (U0, U1, U2, and U3)*
| FFA (% of total FFAs) | U0 | U1 | U2 | U3 |
|---|---|---|---|---|
| C10:0 | 0.051 ± 0.000c | 0.053 ± 0.001b | 0.054 ± 0.000a | 0.053 ± 0.000b |
| C12:0 | 0.056 ± 0.000b | 0.058 ± 0.001a | 0.058 ± 0.001a | 0.058 ± 0.000a |
| C14:0 | 1.167 ± 0.006c | 1.200 ± 0.008b | 1.219 ± 0.005a | 1.198 ± 0.003b |
| C16:0 | 22.161 ± 0.089d | 22.649 ± 0.039b | 22.915 ± 0.046a | 22.485 ± 0.028c |
| C16:1 | 1.868 ± 0.005c | 1.908 ± 0.008b | 1.938 ± 0.012a | 1.927 ± 0.006a |
| C18:0 | 11.306 ± 0.085b | 11.777 ± 0.170a | 11.777 ± 0.216a | 11.372 ± 0.173b |
| C18:1 | 45.637 ± 0.009b | 46.146 ± 0.240a | 46.359 ± 0.246a | 46.307 ± 0.194a |
| C18:2 n6 | 14.802 ± 0.085a | 13.487 ± 0.015c | 13.082 ± 0.070d | 13.944 ± 0.50b |
| C18:3 n3 | 0.799 ± 0.006a | 0.710 ± 0.000c | 0.676 ± 0.005d | 0.747 ± 0.003b |
| C20:1 n9 | 1.050 ± 0.004a | 1.076 ± 0.005a | 1.258 ± 0.331a | 1.068 ± 0.000a |
| C20:2 n6 | 0.875 ± 0.007a | 0.809 ± 0.008c | 0.786 ± 0.008d | 0.841 ± 0.005b |
| ƩSFA | 34.742 ± 0.154c | 35.738 ± 0.121a | 36.024 ± 0.261a | 35.166 ± 0.145b |
| ƩMUFA | 48.555 ± 0.013b | 49.130 ± 0.253a | 49.556 ± 0.315a | 49.302 ± 0.193a |
| ƩPUFA | 16.477 ± 0.095a | 15.006 ± 0.023c | 14.544 ± 0.083d | 15.532 ± 0.056b |
| PUFA/SFA | 0.474 ± 0.002a | 0.420 ± 0.001c | 0.404 ± 0.004d | 0.442 ± 0.001b |
Different superscript letters (a–d) in the same row indicate statistically significant differences at p < .05 (n = 3).
U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w.
Effect of salt mixture on free amino acid composition of the reduced‐sodium restructured bacon under ultrasound treatments (U0, U1, U2, and U3)*
| FAA (mg/100g) | U0 | U1 | U2 | U3 |
|---|---|---|---|---|
| Gly | 8.55 ± 0.02b | 9.31 ± 0.08a | 9.50 ± 0.16a | 8.66 ± 0.24b |
| IIe | 2.99 ± 0.04c | 3.38 ± 0.05b | 3.53 ± 0.09a | 3.07 ± 0.01c |
| Leu | 5.74 ± 0.24c | 7.06 ± 0.24ab | 7.23 ± 0.45a | 6.55 ± 0.05b |
| Ala | 18.96 ± 0.07b | 19.85 ± 0.28a | 20.07 ± 0.36a | 18.97 ± 0.34b |
| Val | 4.54 ± 0.02c | 6.37 ± 0.07a | 6.53 ± 0.15a | 5.47 ± 0.78b |
| Phe | 4.25 ± 0.85a | 6.05 ± 1.34a | 6.11 ± 1.42a | 6.12 ± 0.02a |
| Pro | 4.81 ± 0.27bc | 5.12 ± 0.40ab | 5.45 ± 0.16a | 4.54 ± 0.13c |
| Met | 2.08 ± 0.03c | 3.33 ± 0.05a | 3.46 ± 0.10a | 2.83 ± 0.46b |
| Ser | 5.85 ± 0.08b | 6.77 ± 0.09a | 6.77 ± 0.17a | 5.84 ± 0.04b |
| Thr | 9.99 ± 0.29a | 10.20 ± 0.11a | 10.15 ± 0.45a | 9.15 ± 0.16b |
| Tyr | 2.59 ± 0.91a | 2.35 ± 0.44a | 2.41 ± 0.50a | 2.57 ± 0.05a |
| Arg | 5.35 ± 0.07c | 6.59 ± 0.12a | 6.61 ± 0.17a | 5.88 ± 0.05b |
| Asp | 0.37 ± 0.21b | 0.71 ± 0.01a | 0.92 ± 0.13a | 0.44 ± 0.01b |
| His | 58.73 ± 1.23c | 60.77 ± 0.97ab | 62.26 ± 1.31a | 59.21 ± 0.26bc |
| Glu | 8.26 ± 0.02c | 9.15 ± 0.10b | 9.62 ± 0.18a | 7.91 ± 0.02d |
| Lys | 5.86 ± 0.26c | 6.59 ± 0.15ab | 6.67 ± 0.33a | 6.16 ± 0.23bc |
| Total FAA | 148.96 ± 1.89b | 163.60 ± 0.22a | 167.30 ± 4.75a | 153.38 ± 1.55b |
Different superscript letters (a–d) in the same row indicate statistically significant differences at p < .05 (n = 3).
U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w.
Effect of salt mixture on volatile composition (AU*105) of the reduced‐sodium restructured bacon under ultrasound treatments (U0, U1, U2, and U3)*
| Compounds | Threshold value (μg/kg) | U0 | U1 | U2 | U3 |
|---|---|---|---|---|---|
| Phenols | |||||
| Phenol | 5,501 | 46.95 ± 1.86c | 52.00 ± 5.39bc | 58.79 ± 0.46a | 55.43 ± 1.94ab |
| o‐Cresol | 45 | 21.24 ± 1.15b | 23.06 ± 1.56b | 27.48 ± 0.22a | 25.80 ± 0.94a |
| m‐Cresol | 31 | 22.75 ± 1.38b | 7.36 ± 1.24c | 26.68 ± 1.25a | 25.25 ± 0.91a |
| 2‐Methoxy‐phenol | 3 | 123.95 ± 4.98b | 134.70 ± 10.09b | 156.60 ± 2.84a | 147.65 ± 5.51a |
| 2,6‐Xylenol | 400 | 3.72 ± 0.89ab | 2.69 ± 0.12b | 3.84 ± 0.14a | 3.20 ± 0.53ab |
| 3,5‐Xylenol | 5,000 | 5.52 ± 0.39ab | 6.31 ± 0.71a | 5.94 ± 0.24ab | 5.23 ± 0.23b |
| 3‐Ethylphenol | 140 | 2.45 ± 0.04c | 2.48 ± 0.15c | 2.83 ± 0.07b | 3.18 ± 0.32a |
| 2‐Methoxy‐5‐methylphenol | 13 | 4.46 ± 0.12c | 4.64 ± 0.34bc | 5.41 ± 0.10a | 4.97 ± 0.29ab |
| 2‐Methoxy‐4‐methylphenol | 21 | 57.52 ± 2.83b | 61.62 ± 3.87ab | 66.69 ± 2.95a | 61.78 ± 2.76ab |
| 3,4‐Dimethoxyphenol | – | n.d. | n.d. | 0.77 ± 0.12 | n.d. |
| 2,6‐Dimethoxyphenol | 263 | 5.04 ± 0.68b | 6.69 ± 0.52a | 4.55 ± 0.47bc | 4.07 ± 0.10c |
| Subtotal | 293.60 ± 13.50b | 301.55 ± 22.46b | 359.58 ± 7.10a | 336.55 ± 13.53a | |
| Aldehydes | |||||
| Hexanal | 5 | 6.02 ± 0.20c | 10.48 ± 2.57b | 13.79 ± 1.56a | 11.68 ± 0.65ab |
| Furfural | 3,000 | 98.58 ± 6.13d | 201.91 ± 14.82c | 254.37 ± 18.98b | 300.25 ± 19.48a |
| 5‐Methyl furfural | 1,110 | 38.12 ± 1.45c | 49.36 ± 2.95b | 57.37 ± 1.59a | 57.44 ± 2.31a |
| Nonanal | 1.1 | 16.94 ± 0.69b | 23.82 ± 6.61a | 30.59 ± 2.40a | 30.53 ± 1.06a |
| Decanal | 0.2 | 3.93 ± 0.09a | 0.77 ± 0.12c | 1.26 ± 0.20b | 0.75 ± 0.04c |
| Neral | 53 | 0.20 ± 0.10 | n.d. | n.d. | n.d. |
| Citral | 120 | n.d. | 0.46 ± 0.12 | n.d. | n.d. |
| Subtotal | 163.80 ± 6.42d | 286.81 ± 22.87c | 357.38 ± 23.74b | 400.64 ± 22.24a | |
| Ketones | |||||
| Cyclopentanone | 9,300 | 2.46 ± 0.20b | 2.59 ± 0.40b | 3.63 ± 0.09ab | 4.76 ± 1.50a |
| 1‐Acetoxyacetone | – | n.d. | n.d. | n.d. | 0.58 ± 0.03 |
| 2‐Octanone | 50 | 5.37 ± 0.52a | n.d. | 4.17 ± 0.68b | 4.01 ± 0.74b |
| 2‐Hexanone | 560 | n.d. | 3.87 ± 0.99 | n.d. | n.d. |
| 2‐Methylcyclopentenone | – | 11.91 ± 1.02b | 13.37 ± 1.16b | 18.59 ± 2.01a | 17.75 ± 2.27a |
| Acetonylacetone | – | 2.06 ± 0.74a | 2.02 ± 0.87a | 1.78 ± 0.26a | 1.93 ± 0.08a |
| 3,4‐Dimethylcyclopentenone | – | 3.00 ± 0.49a | 3.48 ± 1.34a | 3.74 ± 0.56a | 3.11 ± 0.48a |
| 3‐Methyl‐3‐cyclohexen‐1‐one | – | 2.43 ± 0.20b | 2.75 ± 0.10a | n.d. | 2.89 ± 0.01a |
| 2‐Methyl‐2‐propynyl‐2‐acetone | – | 1.23 ± 0.34a | n.d. | 1.27 ± 0.16a | n.d. |
| 2,3‐Octanedione | – | n.d. | n.d. | n.d. | 1.26 ± 0.05 |
| Methyl cyclopentenolone | 300 | n.d. | 9.22 ± 0.79 | n.d. | n.d. |
| 2,3‐Dimethyl‐2‐cyclopentenone | – | 14.59 ± 0.46d | 18.05 ± 1.15c | 25.22 ± 1.24a | 21.30 ± 1.21b |
| 3‐Ethyl‐2‐cyclopenten−1‐one | – | 5.72 ± 0.34b | 0.44 ± 0.02c | 7.65 ± 0.56a | 7.16 ± 0.38a |
| Mesityl oxide | – | 0.38 ± 0.00b | n.d. | 0.62 ± 0.05a | 0.54 ± 0.12a |
| 4,4‐Dimethyl‐2‐cyclohexen‐1‐one | – | 0.60 ± 0.07a | 0.55 ± 0.10a | 0.62 ± 0.06a | 0.52 ± 0.02a |
| cis‐Hexahydro‐7a‐methyl‐2(3H)‐benzofuranone | – | n.d. | n.d. | 0.22 ± 0.05 | n.d. |
| Siro[5.5]undecane‐5,11‐dione | – | n.d. | n.d. | n.d. | 0.48 ± 0.26 |
| Subtotal | 49.76 ± 3.51b | 56.35 ± 5.26b | 67.52 ± 4.24a | 66.31 ± 6.96a | |
| Hydrocarbons | |||||
| Propan‐2‐ylidenecyclopentane | – | n.d. | n.d. | 3.19 ± 0.25 | n.d. |
| 1‐Acetylcyclohexene | – | n.d. | 1.70 ± 0.13a | n.d. | 0.59 ± 0.12b |
| 2,2,5‐Trimethyldecane | – | n.d. | 13.07 ± 0.90a | 16.99 ± 2.51a | 18.15 ± 4.70a |
| 3,4‐Dimethylhexa‐2,4‐diene | – | n.d. | n.d. | 4.89 ± 0.20b | 5.34 ± 0.31a |
| Propan‐2‐ylidenecyclohexane | – | 2.85 ± 0.12c | 3.19 ± 0.20bc | 4.06 ± 0.04a | 3.55 ± 0.31b |
| 3‐Methylundecane | – | 1.64 ± 0.11c | 1.83 ± 0.17c | 2.39 ± 0.13b | 2.88 ± 0.16a |
| Bis‐(R,R)1,1‐(1,2‐dimethyl‐1,2‐ethylene)cyclohexane | – | 0.55 ± 0.03a | 0.51 ± 0.10a | 0.54 ± 0.04a | 0.55 ± 0.01a |
| 3,4‐Dimethoxytoluene | – | 1.41 ± 0.03b | 1.41 ± 0.13b | 1.74 ± 0.03a | 1.77 ± 0.18a |
| Tridecane | – | n.d. | n.d. | n.d. | 0.54 ± 0.04 |
| Tetradecane | 1,000 | 0.37 ± 0.02b | 0.39 ± 0.14b | 0.61 ± 0.09a | n.d. |
| 3‐Methyltridecane | – | 0.71 ± 0.05ab | 0.74 ± 0.11ab | 0.65 ± 0.09b | 0.85 ± 0.04a |
| Pentadecane | – | n.d. | 1.01 ± 0.08 | n.d. | n.d. |
| Hexadecane | – | 1.05 ± 0.07c | n.d. | 1.80 ± 0.10a | 1.48 ± 0.01b |
| 1,2,3‐Trimethoxybenzene | – | 1.53 ± 0.15a | 1.10 ± 0.06bc | 1.27 ± 0.21b | 0.98 ± 0.05c |
| Subtotal | 10.11 ± 0.20c | 24.95 ± 1.19b | 38.14 ± 2.76a | 36.68 ± 5.59a | |
| Alcohols | |||||
| 2‐Furanmethanol | 4,500 | 8.67 ± 0.29 | n.d. | n.d. | n.d. |
| 3‐Furancarbinol | 2,000 | n.d. | 8.18 ± 0.71a | n.d. | 4.35 ± 0.31b |
| Linalool | 37 | 0.87 ± 0.08a | 0.35 ± 0.03b | 0.32 ± 0.25b | 0.15 ± 0.05b |
| Subtotal | 9.55 ± 0.22a | 8.53 ± 0.72b | 0.32 ± 0.25d | 4.50 ± 0.36c | |
| Heterocycles and others | |||||
| 3‐Methylpyridine | – | 3.10 ± 0.21a | 2.60 ± 0.31a | 3.37 ± 0.32a | 4.14 ± 1.88a |
| 2‐Acetylfuran | 15,025 | 39.44 ± 1.85d | 121.20 ± 9.33b | 145.50 ± 4.64a | 55.41 ± 4.80c |
| 3,5‐Dimethylpyridine | – | 1.62 ± 0.33a | 2.26 ± 1.43a | 1.80 ± 0.13a | n.d. |
| 3,4‐Lutidine | – | n.d. | n.d. | n.d. | 1.15 ± 0.06 |
| 2‐Propionylfuran | – | 5.13 ± 0.10c | 5.21 ± 0.30c | 6.81 ± 0.12a | 6.15 ± 0.29b |
| 2‐Acetyl‐5‐methylfuran | – | 4.23 ± 0.07b | 4.58 ± 0.50b | 5.85 ± 0.52a | 6.10 ± 0.45a |
| 3‐Acetoxypyridine | – | 82.20 ± 6.33a | 23.49 ± 1.49c | n.d. | 71.82 ± 1.13b |
| 2‐Methyl‐5‐propionylfuran | – | 0.48 ± 0.14a | 0.45 ± 0.07a | 0.44 ± 0.04a | 0.36 ± 0.11a |
| 1,2‐Dimethoxybenzene | – | 5.17 ± 1.13a | 5.69 ± 0.48a | 6.10 ± 0.30a | 5.10 ± 0.04a |
| Subtotal | 141.39 ± 5.31b | 165.48 ± 10.61a | 169.87 ± 4.63a | 150.22 ± 8.57b | |
| Total | 668.20 ± 19.70c | 843.68 ± 61.12b | 992.81 ± 22.63a | 994.91 ± 57.24a | |
Different superscript letters (a–d) in the same row indicate statistically significant differences at p < .05 (n = 3). AU: area units resulting of counting the total ion chromatogram (TIC) for each compound. –: not queried; n.d.: not detected.
U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w.
The ROAVs of major volatile flavor compounds of the reduced‐sodium restructured bacon under ultrasound treatment with different salt mixture content (U0, U1, U2, and U3)*
| Compounds | Threshold value (μg/kg) | U0 | U1 | U2 | U3 |
|---|---|---|---|---|---|
| o‐Cresol | 45 | 1.14 | 1.14 | 1.17 | 1.16 |
| m‐Cresol | 31 | 1.78 | 0.53 | 1.65 | 1.65 |
| 2‐Methoxy‐phenol | 3 | 100.00 | 100.00 | 100.00 | 100.00 |
| 2‐Methoxy‐4‐methylphenol | 21 | 6.63 | 6.54 | 6.08 | 5.98 |
| Hexanal | 5 | 2.92 | 4.67 | 5.28 | 4.75 |
| Nonanal | 1.1 | 37.27 | 48.23 | 53.27 | 56.39 |
| Decanal | 0.2 | 47.54 | 8.57 | 12.05 | 7.64 |
| 2‐Methoxy‐5‐methylphenol | 13 | 0.83 | 0.79 | 0.80 | 0.78 |
| Furfural | 3,000 | 0.08 | 0.15 | 0.16 | 0.20 |
| 5‐Methyl furfural | 1,110 | 0.08 | 0.10 | 0.10 | 0.11 |
Other volatile compounds (ROAV < 0.1) are not included in the table.
U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w.
The sensory scores of the reduced‐sodium restructured bacon under ultrasound treatment with different salt mixture content (U0, U1, U2, and U3)*
| U0 | U1 | U2 | U3 | |
|---|---|---|---|---|
| Aroma | 6.40 ± 0.82b | 6.40 ± 1.14b | 7.90 ± 0.89a | 6.90 ± 1.14ab |
| Taste | 6.60 ± 1.14ab | 6.30 ± 1.10b | 7.80 ± 0.76a | 7.50 ± 1.00ab |
| Color | 6.90 ± 0.74a | 7.00 ± 0.71a | 6.90 ± 1.24a | 6.80 ± 0.57a |
| Texture | 7.10 ± 1.14a | 7.10 ± 0.89a | 7.00 ± 0.79a | 5.80 ± 0.57b |
| Aftertaste | 7.50 ± 0.50a | 7.00 ± 0.79a | 7.40 ± 0.82a | 6.90 ± 0.89a |
| Overall quality | 6.80 ± 0.41b | 6.62 ± 0.54b | 7.58 ± 0.49a | 6.96 ± 0.27b |
Different superscript letters (a–b) in the same row indicate statistically significant differences at p < .05 (n = 9).
U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w.
FIGURE 2The PCA loading plot (a) for volatile compounds of the reduced‐sodium restructured bacon under ultrasound treatment with difference treatment (n = 3); The PCA loading plot (b) of key volatile compounds, lipid oxidation, protein oxidation, FFAs, FAA, and sensory evaluation of the reduced‐sodium restructured bacon under ultrasound treatment. *U0: 1.5%NaCl + UT 600 w; U1: 1.5%NaCl + 0.125%KCl + 0.125%CaCl2 + UT 600 w; U2: 1.5%NaCl + 0.25%KCl + 0.25%CaCl2 + UT 600 w; U3: 1.5%NaCl + 0.50%KCl + 0.50%CaCl2 + UT 600 w